Stock Price
238.40
Daily Change
-5.25 -2.15%
Monthly
-39.96%
Yearly
-62.91%
Q1 Forecast
285.47

Novo Nordisk reported DKK118.72B in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Bausch Health Companies USD 21.04B 696M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Novo Nordisk DKK 118.72B 15.94B Mar/2025
Pacira USD 376.72M 203.77M Sep/2025
Sanofi EUR 21.76B 530M Sep/2025
Supernus Pharmaceuticals USD 42.21M 10.44M Sep/2025